Davis's Drug Guide
Safyral
Phase I
drospirenone 3 mg + ethinyl estradiol 30 mcg + levomefolate 0.451 mg
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Safyral." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109806/all/Safyral.
Vallerand AHA, Sanoski CAC. Safyral. Davis's Drug Guide. F.A. Davis Company; 2026. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109806/all/Safyral. Accessed June 30, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Safyral. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109806/all/Safyral
Vallerand AHA, Sanoski CAC. Safyral [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 June 30]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109806/all/Safyral.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Safyral
ID - 109806
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/109806/all/Safyral
PB - F.A. Davis Company
ET - 20
DB - Pediatrics Central
DP - Unbound Medicine
ER -
